KT&G (033780) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
7 May, 2026Executive summary
Achieved record-high global cigarette revenue in Q1 2026, with volume up 15%, revenue up 24.6%, and operating profit up 56.1% year-over-year, with trends expected to continue throughout the year.
Significant progress in global expansion, especially in tobacco and health-functional food segments, with all regions showing stable sales growth and a new shareholder return policy emphasizing stronger dividends.
NGP (Next Generation Products) business grew domestically and internationally, with domestic stick market share reaching 47.4%.
HFF (Health Functional Food) business revenue rose 5.8% and operating profit surged 53.3%, driven by promotions, structural transformation, and domestic demand.
Completed full cancellation of treasury shares worth KRW 1.8 trillion, exceeding targets ahead of schedule.
Financial highlights
Q1 consolidated revenue rose 14.3% year-over-year to KRW 1.7036 trillion.
Operating profit increased 27.6% to KRW 364.5 billion.
Net income grew 46.6% to KRW 378.2 billion, aided by currency-related non-operating profits.
EPS increased 54.7% to KRW 3,666.
EBITDA rose 25% to KRW 442.7 billion, with a margin of 26%.
Outlook and guidance
Overseas CC business growth and triple growth in volume, revenue, and operating profit expected to continue throughout the year.
New NGP products planned for launch every quarter in 2026 to reinforce market dominance.
Mid-to-upper 20% ASP growth expected for global CC business from 2024 to 2027.
New mid- to long-term shareholder return policy focusing on stronger dividends to be announced in H2 2026.
Continued innovative product launches and direct business expansion in APAC and Eurasia are planned.
Latest events from KT&G
- Record revenue and operating profit growth, with higher shareholder returns and ongoing risk management.033780
Q2 202513 Feb 2026 - Double-digit profit growth led by global CC, but net income fell amid risk and expense pressures.033780
Q1 202513 Feb 2026 - Record revenue, strong global growth, and top-tier shareholder returns defined 2024.033780
Q4 202413 Feb 2026 - Record tobacco growth and major shareholder returns amid lower net income and real estate.033780
Q3 202413 Feb 2026 - Q2 profit and net income surged, but 2024 outlook was cut amid HFF and real estate weakness.033780
Q2 202413 Feb 2026 - 2025 saw record revenue, profit, and shareholder returns, led by global CC and real estate growth.033780
Q4 20255 Feb 2026 - Record Q3 revenue and profit, with net income up 73.4% and raised full-year guidance.033780
Q3 202513 Nov 2025 - Accelerated global growth, record shareholder returns, and new Altria partnership drive expansion.033780
Investor Day 2025 Presentation23 Sep 2025